Restless Legs Syndrome
📧 Sign up to get email alerts when something new happens for Restless Legs Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-10-15Clinical Trial Update: Apelin in Willis Ekbom Disease
Clinical trial update on Apelin for Restless legs syndrome; status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome [Phase 3]
A Phase 3 trial evaluating four transdermal doses of rotigotine for idiopathic restless legs syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Rotigotine Restless Legs Syndrome Dose Finding Trial [Phase 2]
A Phase 2 dose-finding trial of rotigotine for idiopathic restless legs syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome [Phase 3]
This clinical trial update reports on a Phase 3 study evaluating the efficacy and safety of transdermal rotigotine in adults with idiopathic…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome [Phase 3]
Phase 3 trial evaluating three transdermal doses of rotigotine for idiopathic restless legs syndrome has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)
An observational study of Sifrol (pramipexole) in patients with primary restless legs syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome [Phase 3]
An extension Phase 3 trial evaluated long-term treatment with transdermal rotigotine for idiopathic restless legs syndrome; the study has co…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)
An observational study of Sifrol (pramipexole) in patients with primary restless legs syndrome has completed, according to the update.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
This is a completed clinical trial update reporting results of a long-term use survey of BI-Sifrol tablets in patients with Restless Legs Sy…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS) [Phase 3]
A Phase 3 trial evaluating rotigotine's effects on all-day functioning and quality of life in adults with moderate to severe restless legs s…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Prevalence of OSAS in Chinese Elderly and Its CPAP Compliance [NA]
A completed clinical trial update reporting the prevalence of obstructive sleep apnea and CPAP compliance among elderly Chinese participants…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation
A completed clinical trial assessed the effect on Restless Legs Syndrome symptom severity after switching patients who experienced augmentat…
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Study of SPM 962 in Patients With Restless Legs Syndrome (RLS) [Phase 3]
A Phase 3 clinical trial evaluating SPM 962 for idiopathic restless legs syndrome has completed, with results posted in 2014.
-
FDA approval · 2014-06-03FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's original application for pramipexole dihydrochloride, a generic formulation indicated for trea…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients [Phase 2]
A placebo-controlled Phase 2 study evaluating SPM 962 in adults with restless legs syndrome has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome [Phase 2]
A long-term extension of a late-stage Phase II trial evaluating SPM 962 in idiopathic restless legs syndrome has completed, with results pos…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Targeting Dopamine Therapy in RLS [NA]
This clinical trial update discusses a dopamine-targeting therapy approach for Restless Legs Syndrome, with the trial status currently unkno…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Biotin Deficiency and Restless Legs Syndrome [NA]
A clinical trial investigating biotin deficiency and restless legs syndrome in patients with end-stage renal disease has completed.
-
FDA approval · 2013-12-10FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Torrent Pharmaceuticals Limited, authorizing a supplemental AND…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.) [Phase 3]
Completed Phase 3 clinical trial evaluating open-label pramipexole with titration in idiopathic restless legs syndrome patients who initiall…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) [Phase 3]
Phase 3 trial comparing pramipexole to placebo in restless legs syndrome has completed, reporting on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome [Phase 3]
A Phase 3 trial comparing pramipexole to Levodopa/Benserazide (Madopar) for restless legs syndrome has completed; the update discusses effic…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS) [Phase 2]
A Phase 2 dose-finding study of pramipexole (Sifrol) for idiopathic restless legs syndrome has completed.
-
CLINICAL_TRIALS research · 2013-11-01Clinical Trial Update: Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life
A completed non-interventional observational study evaluated how pramipexole affects quality of life in people with restless legs syndrome.
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients [Phase 3]
This clinical trial update notes the completion of a Phase 3 trial evaluating the efficacy and safety of pramipexole for moderate-to-severe …